Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Treatment for Donor Sites
NCT00591916Phase 3Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jan 2006
- Primary completion
- Nov 2010
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial of hyaluronan + thrombin in burn injury (3 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Epidermal regeneration (donor site healing). Planned start Jan 2006; status: withdrawn.
02
Drugs
hyaluronan + thrombin
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00591916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591916.